LevitasBio
Latest round
- Series C
Last raised
- Sep 2022
Total raised
- $62M
Investors
- 4
About LevitasBio
Founded in 2017 by Gozde Durmus, Lars Steinmetz, and Utkan Demirci and based in California, US, LevitasBio, Inc. is a provider of single-cell imaging and profiling technology. As of 2022, Martin Pieprzyk is the CEO of the company. In September 2022, LevitasBio, Inc. The company provides products such as LeviCell EOS, a next-generation sample processing platform with throughput and temperature control; LeviPrep, cold tissue dissociation kits; LeviSelect, specific surface marker enrichment assays; and LeviMetrics, integrated analysis software for real-time on-platform analysis. The firm offers its technology platform, which is based on magnetic levitation, to initially address the critical need for sample enrichment by providing gentle, label-free viable cell separation free from the deleterious effects imparted by conventional sample preparation methods. LevitasBio's applications include viable cell enrichment, single-cell genomics, CRISPR, tissue processing, and tumor processing.
Who invested in LevitasBio
4 investors across 3 rounds
See all investors in LevitasBio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about LevitasBio
Who invested in LevitasBio?
LevitasBio has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has LevitasBio raised?
LevitasBio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did LevitasBio last raise money?
LevitasBio's most recent round on record is a Series C, in Sep 2022.
What does LevitasBio do?
Founded in 2017 by Gozde Durmus, Lars Steinmetz, and Utkan Demirci and based in California, US, LevitasBio, Inc.
Where is LevitasBio headquartered?
LevitasBio is headquartered in Menlo Park, US.
Which VCs invest in companies like LevitasBio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at LevitasBio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like LevitasBio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.